Price History

Hover for the daily close. The dotted line marks the period open.

Compare AVR with… →

AVR Key Statistics

As of Sep 4, 2026

Trading

Open: $8.67
Previous Close: $8.72
Day's Range: 8.66–9.10
52-Week Range: 3.30–11.06
Volume: 362.90K

Valuation

Market Cap: $881.02M
P/E Ratio: unprofitable
P/S ratio: 392.96
EPS (ttm): −1.95

Financials (FY)

Revenue (FY): $2.73M−14.56%
Net Income (FY): −$46.02M
Profit margin: 0.00%
Shares Outstanding: 97.46M
1-Year Return: +126.57%

Dividend and dates

Earnings Date: November 12, 2026estimated
Avg Volume: 1.08M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

AVR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−0.36%−10.57%+81.16%

2024*20252026*

Year	Return
2026 (partial year)	+81.16%
2025	−10.57%
2024 (partial year)	−0.36%

As of September 4, 2026.

AVR Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

202120222023

Fiscal year	Revenue	Net income	Net margin
2023	$2.73M	−$46.02M	−1682.8%
2022	$3.20M	−$30.56M	−954.9%
2021	$5.83M	−$17.17M	−294.5%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2023	$2.73M	$876.80K	−$46.66M	−$46.02M	−1682.8%
2022	$3.20M	$298.38K	−$31.49M	−$30.56M	−954.9%
2021	$5.83M	$1.91M	−$16.32M	−$17.17M	−294.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2023.

AVR Valuation vs Medical Devices Median

Median of 151 stocks

Metric	AVR	Medical Devices median	vs median
P/S ratio	392.96	2.98	132.0x the median
Profit margin	0.00%	−1.69%	1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Anteris Technologies Global Corp. (AVR) at $881.02M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 174 employees.

AVR last closed at $9.04 on September 4, 2026. That is +$0.32 (+3.67%) against the previous close. The 52-week range on file runs from $3.30 to $11.06. The latest close sits 173.94% above that 52-week low.

Financial Health

Fiscal 2023 revenue came to $2.73M. That is −14.56% against the prior fiscal year, when revenue was $3.20M. The same year closed with a net loss of $46.02M. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −1.95.

Across the 3 fiscal years on file, revenue moves from $5.83M in 2021 to $2.73M in 2023. Of those 3 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 392.96. On price-to-sales that is 132 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Daily returns over the trailing 1 year annualize to a volatility of 71.17%. Over the trailing twelve months the price has returned +126.57%. The stored price history starts on December 13, 2024, and the total return since then is +61.43%.

Growth & Income

The record shows no dividend for AVR.

The record holds one complete calendar year, 2025, which returned −10.57%. So far in 2026 the price is +81.16%.

Peer Comparison

Anteris Technologies Global Corp. (AVR) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Anteris Technologies Global Corp.	AVR	$881.02M	—
Abbott Laboratories	ABT	$187.45B	35.1
Medtronic plc.	MDT	$120.46B	22.9
Stryker Corporation	SYK	$116.27B	31.9

The Medical Devices industry average P/E ratio is 26.8x. Anteris Technologies Global Corp. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

MDT

Medtronic plc.

$120.46B

SYK

Stryker Corporation

$116.27B

BSX

Boston Scientific Corporation

$69.27B

EW

Edwards Lifesciences Corporation

$51.82B

DXCM

DexCom, Inc.

$33.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Visit website →

Anteris Technologies Global Corp. (AVR) Stock Analysis